Full-range Veterinary Vaccine Solutions
Empower Healthy & Efficient Farming
| Availability: | |
|---|---|
| Quantity: | |
【COMPOSITION AND CONTENT】
This product contains inactivated Newcastle Disease Virus Strain La Sota (CVCC AV1615).
【CHARACTER】
Homogeneous emulsion.
【INDICATIONS】
For the prevention of Newcastle disease in chickens. The immune duration lasts 4 months.
【DOSAGE AND ADMINISTRATION】
Administer via subcutaneous injection in the neck.
For chicks aged within 14 days: Inject 0.2 mL per chicken. Meanwhile, perform nasal or eye dropping vaccination with diluted live La Sota strain or II strain vaccine according to the doses specified on the bottle label; aerosol vaccination with live II strain vaccine is also acceptable. A single vaccination with the above method is sufficient for broilers.
For chickens aged over 60 days: Inject 0.5 mL per bird, with an immune duration of up to 10 months.
For laying hens previously vaccinated with live vaccine: Inject 0.5 mL per chicken 14 to 21 days before the start of laying, which can provide protection throughout the entire laying period.
【PRESENTATION】
100 mL/bottle;250 mL/bottle;500 mL/bottle;
【STORAGE AND SHELF LIFE】
Store at 2–8 °C. Shelf life: 12 months from the date of manufacture.
For use only under veterinary supervision.
1. Inactivated classic La Sota strain ensures high safety and stable protection: Refined from standard La Sota strain through thorough inactivation technology, the vaccine features pure strain lineage and strong antigenicity. With zero live virus residue and zero virus diffusion risk, it causes extremely low immune stress and ensures safe and stable daily epidemic prevention for healthy chicken flocks.
2. Graded ultra-long immune duration reduces repeated immunization frequency: The vaccine achieves stepped long-term protection with a conventional 4-month immune period and a maximum 10-month protection period for adult chickens. Pre-laying vaccination covers the entire laying cycle, effectively reducing repeated immunization, labor costs and vaccination stress.
3. Combined live and inactivated vaccination improves hierarchical immunity: The combined immunization mode of live vaccine basic immunity and inactivated vaccine booster immunity builds a dual immune barrier of mucosal protection and long-term humoral protection, realizing higher antibody level, better uniformity and more thorough disease prevention.
4. Uniform stable emulsion ensures durable antibody persistence: The uniform and stable emulsion features slow antigen release and good absorption. It continuously stimulates the production of stable protective antibodies after injection, providing long-term and reliable defense against Newcastle disease wild virus.
Q: What type of vaccine is this? What diseases does it prevent?
A: This is an inactivated Newcastle disease vaccine, a non-prescription veterinary drug prepared with inactivated La Sota strain. It is specially used for the prevention of chicken Newcastle disease and serves as the core vaccine for long-term booster immunization and full-cycle protection during the laying period.
Q: What are the core advantages and protection characteristics of the vaccine?
A: The inactivated strain features high safety and zero virus diffusion risk. With age-differentiated immune schemes, ultra-long 10-month maximum protection cycle and full laying cycle coverage, it realizes stable and long-term epidemic prevention through combined immunization, perfectly suitable for large-scale poultry farms.
Q: What are the vaccination schemes and dosages for chickens of different ages and categories?
A: Chicks within 14 days old: 0.2mL per bird via subcutaneous neck injection, combined with live vaccine immunization; adult chickens over 60 days old: 0.5mL per bird; pre-laying hens: 0.5mL per bird injected 14–21 days before laying to achieve full laying cycle protection.
Q: What are the key operation specifications before vaccination?
A: Warm the refrigerated vaccine to room temperature and shake fully before use. Strictly disinfect the injection site and prohibit the use of frozen, demulsified or deteriorated vaccines to ensure vaccination safety and efficacy.